SGMO:OTCMKTS
Sangamo Therapeutics Inc
$0.15
arrow_downward
-0.76%(-0.0011) 1D
Jun 10, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SGMO...
Open
$0.14
High
$0.15
Low
$0.14
Mkt. cap
61.79M
Avg. vol.
12.49M
Volume
2.32M
52-wk high
$0.77
52-wk low
$0.10
EPS
-$0.38
Beta
1.30
Shares outstanding
414.29M
No. of employees
142
Open
$0.14
High
$0.15
Low
$0.14
Mkt. cap
61.79M
Avg. vol.
12.49M
Volume
2.32M
52-wk high
$0.77
52-wk low
$0.10
EPS
-$0.38
Beta
1.30
Shares outstanding
414.29M
No. of employees
142
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to SGMO in the past 3 months
Hold
Buy
0
Hold
1
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for SGMO in the last 3 months.
Highest
Current $0.15
$2.00 (+1,242.28%)
Average
$2.00 (+1,242.28%)
Lowest
$2.00 (+1,242.28%)
News stories
From sources across the web
Profile
Sangamo Therapeutics, Inc. is an American biotechnology company based in Richmond, California, that develops cell and gene therapies for severe genetic diseases. Wikipedia
About Sangamo Therapeutics Inc
CEOSandy Macrae
Employees142
Founded1995
HeadquartersRichmond, California, United States
SectorBiotechnology
Websitesangamo.com
AI content may include mistakes. Learn more